CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in QURE — uniQure N.V.
CIK 884546
SAN FRANCISCO, CA
Position in QURE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,145,180
-$2,538,490 QoQ
Shares Held
375,852
+3.6% QoQ
Ownership
0.596%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. QURE ranks #122 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in QURE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,145,180 | 375,852 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,683,670 | 362,878 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,878,073 | 357,685 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,083,458 | 292,931 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,967,989 | 279,999 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $4,767,846 | 269,980 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,366,965 | 277,275 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,168,433 | 260,811 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,224,548 | 235,490 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,505,573 | 222,389 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,617,190 | 241,012 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,544,429 | 222,027 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,411,062 | 219,020 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,977,402 | 219,559 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,981,866 | 212,253 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,347,128 | 179,567 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,282,885 | 181,676 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,675,169 | 177,202 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,606,167 | 175,138 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $5,631,872 | 182,853 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $5,941,736 | 176,365 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,098,418 | 168,791 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,132,636 | 166,512 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||